Cargando…
Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey
BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited intereste...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304618/ https://www.ncbi.nlm.nih.gov/pubmed/30627443 http://dx.doi.org/10.1155/2018/2159147 |
_version_ | 1783382402103508992 |
---|---|
author | Fujita, Motoki Oda, Yasutaka Kaneda, Kotaro Kawamura, Yoshikatsu Nakahara, Takashi Todani, Masaki Yagi, Takeshi Koga, Yasutaka Tsuruta, Ryosuke |
author_facet | Fujita, Motoki Oda, Yasutaka Kaneda, Kotaro Kawamura, Yoshikatsu Nakahara, Takashi Todani, Masaki Yagi, Takeshi Koga, Yasutaka Tsuruta, Ryosuke |
author_sort | Fujita, Motoki |
collection | PubMed |
description | BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited interested institutions to join the COP-J Study, a prospective observational study of CO poisoning in Japan. RESULTS: Forty-eight (63%) of 76 institutions replied to the questionnaire. Thirty-three institutions (69%) administered HBO(2) therapy to patients with CO poisoning, and 15 institutions (31%) did not. Consciousness disturbance on arrival, exposure to CO for a long time, and elevation of arterial carboxyhemoglobin (CO-Hb) were the major indications for HBO(2) therapy. The maximum therapeutic pressures were 2.0, 2.5, and 2.8 atmospheres absolute (ATA) at 19 (58%), 6 (18%), and 8 (24%) institutions, respectively. The number of HBO(2) sessions on the first day was 1–3, and 1–7 sessions were administered on days 2–7. Seventeen (35%) institutions treated patients with delayed neurological sequelae (DNS) and 15 of them used HBO(2) therapy for DNS. CONCLUSIONS: This survey indicates that HBO(2) therapy for CO poisoning was varied in both the indications and practice regimens used in Japan. |
format | Online Article Text |
id | pubmed-6304618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-63046182019-01-09 Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey Fujita, Motoki Oda, Yasutaka Kaneda, Kotaro Kawamura, Yoshikatsu Nakahara, Takashi Todani, Masaki Yagi, Takeshi Koga, Yasutaka Tsuruta, Ryosuke Emerg Med Int Research Article BACKGROUND: The aim of this study was to identify practice differences in the treatment of carbon monoxide (CO) poisoning with or without hyperbaric oxygen (HBO(2)) therapy in Japan. MATERIALS AND METHODS: Using an online survey website (Google form), we created a questionnaire and invited interested institutions to join the COP-J Study, a prospective observational study of CO poisoning in Japan. RESULTS: Forty-eight (63%) of 76 institutions replied to the questionnaire. Thirty-three institutions (69%) administered HBO(2) therapy to patients with CO poisoning, and 15 institutions (31%) did not. Consciousness disturbance on arrival, exposure to CO for a long time, and elevation of arterial carboxyhemoglobin (CO-Hb) were the major indications for HBO(2) therapy. The maximum therapeutic pressures were 2.0, 2.5, and 2.8 atmospheres absolute (ATA) at 19 (58%), 6 (18%), and 8 (24%) institutions, respectively. The number of HBO(2) sessions on the first day was 1–3, and 1–7 sessions were administered on days 2–7. Seventeen (35%) institutions treated patients with delayed neurological sequelae (DNS) and 15 of them used HBO(2) therapy for DNS. CONCLUSIONS: This survey indicates that HBO(2) therapy for CO poisoning was varied in both the indications and practice regimens used in Japan. Hindawi 2018-12-04 /pmc/articles/PMC6304618/ /pubmed/30627443 http://dx.doi.org/10.1155/2018/2159147 Text en Copyright © 2018 Motoki Fujita et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Fujita, Motoki Oda, Yasutaka Kaneda, Kotaro Kawamura, Yoshikatsu Nakahara, Takashi Todani, Masaki Yagi, Takeshi Koga, Yasutaka Tsuruta, Ryosuke Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title | Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title_full | Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title_fullStr | Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title_full_unstemmed | Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title_short | Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective Survey |
title_sort | variability in treatment for carbon monoxide poisoning in japan: a multicenter retrospective survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304618/ https://www.ncbi.nlm.nih.gov/pubmed/30627443 http://dx.doi.org/10.1155/2018/2159147 |
work_keys_str_mv | AT fujitamotoki variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT odayasutaka variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT kanedakotaro variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT kawamurayoshikatsu variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT nakaharatakashi variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT todanimasaki variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT yagitakeshi variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT kogayasutaka variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey AT tsurutaryosuke variabilityintreatmentforcarbonmonoxidepoisoninginjapanamulticenterretrospectivesurvey |